Microbubbles comprised of a 90 mol% 1,2-distearoyl-sn-glycero-3- phosphocholine (DSPC) and 10 mol% 1,2-distearoyl-sn-glycero-3- phosphoethanolamine-N-[methoxy(polyethylene glycol)2000] (DSPE-PEG2000) (Avanti Polar Lipids, Alabaster, AL, USA) lipid-shell and a perfluorobutane (FluoroMed, Round Rock, TX, USA) gas-core were manufactured in-house. Size-selected microbubbles with a median diameter of 4–5 µm were isolated from a poly-dispersed microbubble distribution using a differential centrifugation method [29] (link). Their size distributions and concentrations were determined by a particle counter (Multisizer III, Beckman Coulter Inc., Opa Locka, FL, USA). Before each injection into the mouse, their concentrations were diluted using sterile saline to a final concentration of approximately 8×108 number of microbubbles per mL.
Free full text: Click here